Colgan T J, Murphy J, Cole D E, Narod S, Rosen B
Mount Sinai Hospital and the Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada.
Am J Surg Pathol. 2001 Oct;25(10):1283-9. doi: 10.1097/00000478-200110000-00009.
Prophylactic oophorectomy (PO) is an option for women at increased risk for ovarian carcinoma. In this study the value of intensive pathologic examination of PO specimens and accompanying resected tissues in the identification of occult carcinoma and any association of occult carcinoma with BRCA germline mutation status were ascertained. Specimens from 60 consecutive PO patients, who were not suspected of having any ovarian tumor at the time of surgery, were subjected to standardized, complete pathologic examination in a prospective study over an 8-year period. Extra-ovarian tissues were examined as well, but they were not subject to the same standardized protocol. Any occult carcinoma of the ovaries or fallopian tubes was noted. The BRCA status and follow-up of patients were obtained, if available. Fifty-five of the 60 PO specimens did not show any evidence of malignancy. Of the 32 patients in this group followed for >1 year, all are alive and well. The remaining five patients, all BRCA1 mutation positive, showed occult carcinoma of the ovaries and/or in situ or invasive carcinoma of a fallopian tube. One of these five patients has died of abdominal carcinomatosis; four continue to be well, but follow-up is <4 years in all cases. Occult carcinoma is present in a small proportion of BRCA-positive or unknown PO patients and may be of prognostic significance. The entire ovaries and tubes from PO patients should be submitted for histologic examination to identify malignancy.
预防性卵巢切除术(PO)是卵巢癌风险增加女性的一种选择。在本研究中,确定了对PO标本及伴随切除组织进行强化病理检查在隐匿性癌的识别中的价值,以及隐匿性癌与BRCA种系突变状态的任何关联。在一项为期8年的前瞻性研究中,对60例连续接受PO手术的患者的标本进行了标准化的全面病理检查,这些患者在手术时未被怀疑患有任何卵巢肿瘤。还对卵巢外组织进行了检查,但它们未遵循相同的标准化方案。记录了卵巢或输卵管的任何隐匿性癌。如果可能,获取患者的BRCA状态及随访情况。60例PO标本中有55例未显示任何恶性证据。在该组中随访超过1年的32例患者均存活且状况良好。其余5例患者均为BRCA1突变阳性,显示有卵巢隐匿性癌和/或输卵管原位癌或浸润癌。这5例患者中有1例死于腹部癌转移;4例仍状况良好,但所有病例的随访时间均<4年。隐匿性癌在一小部分BRCA阳性或BRCA状态未知的PO患者中存在,可能具有预后意义。应将PO患者的整个卵巢和输卵管送检进行组织学检查以识别恶性肿瘤。